Equinix Inc (EQIX)vsLineage, Inc. Common Stock (LINE)
EQIX
Equinix Inc
$1,017.31
-0.26%
REAL ESTATE · Cap: $102.06B
LINE
Lineage, Inc. Common Stock
$44.59
+0.72%
REAL ESTATE · Cap: $10.91B
Smart Verdict
WallStSmart Research — data-driven comparison
Equinix Inc generates 78% more annual revenue ($9.53B vs $5.36B). EQIX leads profitability with a 14.9% profit margin vs -2.7%. EQIX earns a higher WallStSmart Score of 54/100 (C-).
EQIX
Buy54
out of 100
Grade: C-
LINE
Avoid34
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-82.9%
Fair Value
$559.69
Current Price
$1017.31
$457.62 premium
Intrinsic value data unavailable for LINE.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Strong operational efficiency at 24.3%
Earnings expanding 20.0% YoY
Reasonable price relative to book value
Areas to Watch
Elevated debt levels
Weak financial health signals
Expensive relative to growth rate
Premium valuation, high expectations priced in
0.4% revenue growth
0.0% earnings growth
Operating margin of 3.3%
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : EQIX
The strongest argument for EQIX centers on Market Cap, Operating Margin, EPS Growth. Revenue growth of 12.1% demonstrates continued momentum.
Bull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bear Case : EQIX
The primary concerns for EQIX are Debt/Equity, Piotroski F-Score, PEG Ratio. A P/E of 70.4x leaves little room for execution misses. Debt-to-equity of 1.63 is elevated, increasing financial risk.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Key Dynamics to Monitor
EQIX profiles as a value stock while LINE is a turnaround play — different risk/reward profiles.
EQIX is growing revenue faster at 12.1% — sustainability is the question.
LINE generates stronger free cash flow (-55M), providing more financial flexibility.
Monitor REIT - SPECIALTY industry trends, competitive dynamics, and regulatory changes.
Bottom Line
EQIX scores higher overall (54/100 vs 34/100) and 12.1% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Equinix Inc
REAL ESTATE · REIT - SPECIALTY · USA
Equinix, Inc. is an American multinational company headquartered in Redwood City, California, that specializes in Internet connection and data centers.
Visit Website →Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →Compare with Other REIT - SPECIALTY Stocks
Want to dig deeper into these stocks?